{
    "nctId": "NCT02616224",
    "briefTitle": "A Study To Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer",
    "officialTitle": "N/A",
    "overallStatus": "WITHDRAWN",
    "conditions": "Breast Cancer, HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 0,
    "primaryOutcomeMeasure": "Progression-Free Survival (PFS) For Each Anti-Cancer Treatment Regimen",
    "eligibilityCriteria": "Inclusion Criteria:\n\n- Initially diagnosed with HER2-positive unresectable LA/mBC no more than 6 months prior to enrolment, although they can have received anti-cancer treatment during that time\n\nExclusion Criteria:\n\nThere are no exclusion criteria for entry into this study.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}